TRANSFORMING SURGICAL WAITLIST INTO A ‘PREPARATION LIST’
With
Dr Andrew Marks,
Staff Specialist Anaesthetist & Director of Perioperative Medicine,
Royal North Shore Hospital, Sydney, Australia
Dr Kanika Chaudhri,
Anaesthetic Senior Resident Medical Officer,
Royal North Shore Hospital, Sydney, Australia
CASE STUDY
Filmed in Sydney, Australia | January 2026
The DIAMONDS initiative aims to transform the surgical waitlist into a “preparation list,” enabling healthcare professionals to optimise patient care in the months leading up to elective surgery starting at pre-admission phase.
Patients are will be able to complete pre-admission forms online, receive timely updates, and access educational resources to ensure thorough preparation. This will allow staff to spend more time with patients.
The DIAMONDS pathway, which stands for ‘Digital Pathway of Improved Assessment, Management and Optimisation of Patients for Planned Surgery’ has commenced at Royal North Shore Hospital in Sydney, Australia.
patient care by streamlining assessments and addressing the challenges of the existing paper-based system.
“Staff benefit by having centralised patient information and automated routine tasks, allowing them to focus on providing high-quality care, which ultimately leads to a smoother, more efficient process for everyone involved”, says Dr Kanika Chaudhri.
“Patients benefit from user-friendly tools that enable them to complete pre-admission forms online and access educational resources, enhancing their care experience,” she said.
DIAMONDS is led by the New South Wales, Northern Sydney Local Health District, with collaboration partners Australian Institute of Health Innovation (AIHI) and the George Institute for Global Health.
Source: Adapted from NSLHD news and events
-
Impact of NextSense Institute Research in the field of sensory disabilities
NextSense has a 165 year history of providing services and education for individuals with sensory impairments. With the support of donations, NextSense provides vital support for children and adults, more cochlear implants than any other service in Australia, and is a world leader for research, technology and professional education in the fields of visions and hearing loss.
NextSense clinicians are actively involved in a number of leading research projects—both independently and in collaboration with local and international organisations. The NextSense Institute, part of NextSense is Australia’s leading centre for research and professional education in the field of sensory disabilities.
-
Supportive care for people living with or beyond cancer treatment
Dr Hannah Wardill is a Hospital Research Foundation Fellow and lead of the Supportive Oncology Research Group (SORG), in the School of Biomedicine, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI). She is an Executive Board Member of the Multinational Association for Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO) and Chair of both MASCC/ISOO Patient Partnership Committee & the Palliative Care Clinical Studies Collaborative (PaCCSC) Cancer Symptom Trials (Gut Dysfunction Node; supported by Cancer Australia).
-
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.
